according to the U.S. Centers for Disease Control and Prevention.In a CDC analysis published April 6 in JAMA Pediatrics, researchers found that the majority of MIS-C patients studied did not experience symptoms of COVID-19 when they tested positive for the infection.However, when the patients later developed the inflammatory condition, typically in a time frame of two to five weeks later, fever was among the most common symptoms, the analysis found.
FILE - The Childrens Hospital Los Angeles is seen on Dec. 9, 2020 in Los Angeles, California. (Dania Maxwell / Los Angeles Times via Getty Images) The study looked at nearly 1,800 cases of MIS-C reported to the CDC between March 2020 and mid-January of this year.